SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IVAX, Generic Giant

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Charles Holewinski who wrote (178)4/20/1997 4:51:00 PM
From: harkenman   of 212
 
IVX taken over by anoither company is unlikely. IVX should recover when some sense is brought into the thick skulls of the CEO's of the major generics who will sell at any proce to get sales making the first out haveing to reduce prices significantlly. Watch out for MYL also tanking. BRL who has excellent pipeline and some niche products also reposted loss this Q if it were not for CIPRO/Miles setllement. Give it a year for rcovery!
<Most likely IVAX will be taken over by another stronger company and I am hoping this happens.>
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext